Lattuada E, Lanzafame M, Grosso C, Soldani, et al. F. Optimal fosamprenavir regimen to prevent lipid abnormalities. Acta Biomed. 2009;80(3):200-202. Accessed October 11, 2025. https://mail.mattioli1885journals.com/index.php/actabiomedica/article/view/1171